Neutral
Last updated: 2026-10-08 22:29:09 ET
Pulse AI Brief
Updated Oct 8, 2026 9:03 PM ET
President Trump awarded the nation's highest science and technology honors to Elon Musk, Jensen Huang, Sergey Brin, and AMD CEO Lisa Su, signaling administration alignment with Big Tech leadership on innovation priorities. The gesture reinforces political capital concentration among mega-cap tech donors.
Symbolic validation may reduce regulatory friction for Musk's SpaceX and Neuralink ventures while signaling favorable policy environment for semiconductor and AI infrastructure investments. Huang and Su benefit from implicit endorsement of GPU and chip manufacturing expansion.
The awards reflect deepening alignment between executive branch and tech oligarchs on AI development and space commercialization. Political risk for antitrust enforcement against mega-cap tech firms appears diminished in near term.
The Defense Innovation Unit is looking to recruit about 100 drone pilots and create a standing registry of operators across the military services.
The administration wants to shift science money from universities to private firms. Lawmakers and others have pushed back.
A chippy and at times ugly friendly nonetheless gave Mauricio Pochettino’s side four wins out of four, with another young player making the differen...
SafeWorld, an AI lab building robot safety simulation technologies, has emerged from stealth with $12.2 million in seed funding co-led by Shine Capita...
‘We back pro-crypto candidates who support American innovation’
The stock trading platform seeks to offer tokenized shares in more than 60 US-listed companies under the SEC’s recently introduced innovation exempt...
Hello Robot has received a Phase IIB Small Business Innovation Research grant from the National Institute on Aging, part of the National Institutes of...
US intel chief Clayton may be asked to also oversee AI innovation and development along with “self policing” tech CEOs.
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
RobotPlusPlus (ROBOT++) has closed a Series C round worth “hundreds of millions of RMB (tens of millions of USD)” to accelerate global expansion a...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE